PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.00
-0.0150 (-0.15%)
Apr 7, 2026, 9:31 AM EDT - Market open

PAVmed Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
0.0732.450.380.5
Revenue Growth (YoY)
-97.63%22.14%550.40%-24.60%-
Cost of Revenue
0.224.846.423.610.59
Gross Profit
-0.15-1.85-3.97-3.24-0.09
Selling, General & Admin
17.1736.1548.5360.7334.32
Depreciation & Amortization Expenses
-0.562.021.780.15
Research & Development
4.495.9314.2825.3419.85
Total Operating Expenses
21.6642.6464.8387.8554.31
Operating Income
-21.81-44.49-68.8-91.09-54.39
Interest Income
0.030.250.510.17-
Interest Expense
-0.02-0.05---
Other Non-Operating Income (Expense)
19.3372.71---
Total Non-Operating Income (Expense)
19.3472.910.510.17-
Pretax Income
-2.4728.43-68.29-90.92-54.39
Net Income
0.439.79-66.27-89.26-50.63
Minority Interest in Earnings
-2.87-11.36-15.09-14.26-5.78
Net Income Attributable to Preferred Dividends
4.187.83---
Net Income to Common
0.439.79-66.27-89.26-50.63
Net Income Growth
-98.99%----
Shares Outstanding (Basic)
10000
Shares Outstanding (Diluted)
11000
Shares Change (YoY)
-178.13%21.78%14.91%63.42%
EPS (Basic)
-5.6399.15-170.70-450.90-189.00
EPS (Diluted)
-5.6314.90-274.80-450.90-189.00
Shares Outstanding
0.990.370.290.210.19
Free Cash Flow
-5.24-33.61-52.28-72.53-42.06
Free Cash Flow Per Share
-7.81-50.13-216.86-366.39-244.17
Gross Margin
-207.04%-61.60%-161.83%-858.62%-17.00%
Operating Margin
-30712.68%-1485.38%-2805.67%-24161.01%-10878.60%
Profit Margin
-3477.46%949.15%-3232.59%-27384.08%-11225.20%
FCF Margin
-7376.06%-1122.17%-2132.06%-19237.40%-8412.00%
EBITDA
-21.7-43.29-65.86-88.63-54.17
EBITDA Margin
-30564.79%-1445.38%-2686.09%-23509.28%-10833.40%
EBIT
-21.81-44.49-68.8-91.09-54.39
EBIT Margin
-30712.68%-1485.38%-2805.67%-24161.01%-10878.60%
Updated Mar 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q